Verelan Pm

Cluster Headache, prophylaxis of Cluster headaches, Angina, Unstable + 7 more

Treatment

3 FDA approvals

20 Active Studies for Verelan Pm

What is Verelan Pm

Verapamil

The Generic name of this drug

Treatment Summary

Verapamil is a type of medication used to treat high blood pressure, irregular heartbeats, and chest pain. It was the first medication of its kind to be introduced in the 1960s and belongs to a group of medications called calcium channel blockers, which includes drugs like diltiazem and flunarizine. Verapamil comes in two forms: the S-enantiomer and the R-enantiomer, with the S-enantiomer being more powerful but also metabolized faster.

Calan

is the brand name

Verelan Pm Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Calan

Verapamil

1984

357

Approved as Treatment by the FDA

Verapamil, also called Calan, is approved by the FDA for 3 uses which include Atrial Fibrillation or Flutter and Hypertensive disease .

Atrial Fibrillation or Flutter

Used to treat Atrial Fibrillation or Flutter in combination with Digitoxin

Hypertensive disease

Used to treat High Blood Pressure (Hypertension) in combination with Trandolapril

Heart Rate

Used to treat Heart Rate in combination with Digitoxin

Effectiveness

How Verelan Pm Affects Patients

Verapamil is a drug used to treat heart rhythm problems, chest pain, and high blood pressure. It blocks a certain type of calcium channel in the body, which helps to regulate these conditions. Immediate-release versions must be taken 3 or 4 times a day, but there are extended-release forms that can be taken once a day. Those with severe heart problems should not take verapamil, as it can make these conditions worse.

How Verelan Pm works in the body

Verapamil works by blocking L-type calcium channels. These channels are found in the muscle tissue that makes up the heart and blood vessels, and they help control how much calcium flows into the cells. By blocking these channels, verapamil reduces the amount of calcium that can enter the cells. This causes the blood vessels to relax, which lowers blood pressure and reduces the force the heart needs to pump blood. It also slows down electrical activity in the heart, which is helpful for people with arrhythmias. Verapamil may also affect other calcium channels, potassium channels, and adrenergic receptors to help treat cluster

When to interrupt dosage

The recommended dose of Verelan Pm is contingent upon the diagnosed affliction, including Tachycardia, Ventricular, Unstable Angina Pectoris and Vasospastic Angina. The amount of dosage depends on the method of delivery as depicted in the table below.

Condition

Dosage

Administration

Angina, Stable

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Vasospastic Angina

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Heart Rate

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

prophylaxis of Cluster headaches

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Angina, Unstable

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Cluster Headache

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Hypertensive disease

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Tachycardia, Ventricular

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Tachycardia, Supraventricular

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Atrial Fibrillation or Flutter

180.0 mg, 240.0 mg, , 120.0 mg, 360.0 mg, 100.0 mg, 200.0 mg, 300.0 mg, 80.0 mg, 2.4 mg, 2.5 mg/mL, 40.0 mg, 160.0 mg, 5.0 mg/mL, 10.0 mg/mL

Oral, , Tablet, extended release, Tablet, extended release - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection - Intravenous, Injection, Liquid, Liquid - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous

Warnings

Verelan Pm has eleven contraindications and should not be utilized in tandem with the conditions given in the following table.

Verelan Pm Contraindications

Condition

Risk Level

Notes

Atrioventricular Block

Do Not Combine

Ventricular Tachycardia

Do Not Combine

Atrial Fibrillation

Do Not Combine

Shock, Cardiogenic

Do Not Combine

accessory bypass tract

Do Not Combine

Heart Failure

Do Not Combine

Pulse Frequency

Do Not Combine

Sick Sinus Syndrome

Do Not Combine

Bradycardia

Do Not Combine

Hypotension

Do Not Combine

Pulse Frequency

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Verapamil may interact with Pulse Frequency

There are 20 known major drug interactions with Verelan Pm.

Common Verelan Pm Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The serum concentration of Abemaciclib can be increased when it is combined with Verapamil.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Verapamil.

Acepromazine

Major

Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Verapamil.

Alfuzosin

Major

Verapamil may increase the hypotensive activities of Alfuzosin.

Verelan Pm Toxicity & Overdose Risk

The lowest toxic dose of verapamil in women is 14.4mg/kg and in men is 3.429mg/kg. The toxic dose in rats is 150mg/kg and in mice is 163mg/kg. If someone has overdosed on verapamil, treatment is generally supportive. Symptoms of overdose may include low blood pressure, slow heart rate, irregular heartbeat or non-cardiogenic pulmonary edema. In acute cases, doctors may use gastrointestinal decontamination with cathartics or bowel irrigation. Patients with severe heart depression may require intravenous calcium, atropine, or other treatments. If

image of a doctor in a lab doing drug, clinical research

Verelan Pm Novel Uses: Which Conditions Have a Clinical Trial Featuring Verelan Pm?

34 active clinical trials are assessing the capability of Verelan PM in managing Chronic Stable Angina Pectoris, Tachycardia, Ventricular and Paroxysmal Supraventricular Tachycardia (PSVT).

Condition

Clinical Trials

Trial Phases

Cluster Headache

2 Actively Recruiting

Phase 1, Phase 2

Heart Rate

0 Actively Recruiting

Tachycardia, Supraventricular

2 Actively Recruiting

Phase 3, Phase 2

Angina, Unstable

2 Actively Recruiting

Not Applicable

prophylaxis of Cluster headaches

0 Actively Recruiting

Vasospastic Angina

1 Actively Recruiting

Phase 2, Phase 3

Angina, Stable

0 Actively Recruiting

Atrial Fibrillation or Flutter

0 Actively Recruiting

Tachycardia, Ventricular

0 Actively Recruiting

Hypertensive disease

27 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3

Verelan Pm Reviews: What are patients saying about Verelan Pm?

5

Patient Review

10/6/2007

Verelan Pm for High Blood Pressure

This drug has been effectively treating my hypertension in conjunction with Lisinopril. I have experienced no negative side effects from this medication to date. Because there is no generic for this prescription at the moment, it does come at a higher cost; however, for me, it has been worth every penny.

5

Patient Review

4/5/2011

Verelan Pm for High Blood Pressure

I'm so glad my doctor added Veralan to my Lisinopril and Amlodipine regimen. Not only did it get rid of my daily headaches, but my blood pressure has also lowered significantly in just a couple of weeks. I wish I had known about this sooner!

5

Patient Review

6/11/2009

Verelan Pm for High Blood Pressure

I've been taking this for ten years with no adverse effects. The only thing is that it's pretty drowsy, so make sure to take it at night.

5

Patient Review

10/23/2007

Verelan Pm for High Blood Pressure

I was informed by my pharmacist that there is now a generic option for this medication.

5

Patient Review

11/24/2008

Verelan Pm for Migraine Prevention

I've found that this treatment, in conjunction with Topamax, has reduced the frequency and intensity of my migraines significantly.

5

Patient Review

9/20/2009

Verelan Pm for Prevention of Paroxysmal Supraventricular Tachycardia

I've been using this medication for a while now, and I haven't had any issues with tachycardia since.

2

Patient Review

5/8/2009

Verelan Pm for Migraine Prevention

I have been on this medication for two months and have actually seen an increase in the frequency of my migraines.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about verelan pm

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is verelan used to treat?

"Verapamil is a drug used to lower high blood pressure in order to prevent strokes, heart attacks, and kidney problems. Verapamil works by relaxing blood vessels so that blood can flow more easily and belongs to a class of drugs known as calcium channel blockers."

Answered by AI

Is verelan a calcium channel blocker?

"Verelan's active ingredient is a calcium channel blocker, which lowers blood pressure by reducing the force of the heart's contractions and relaxing the arteries."

Answered by AI

What form is verelan?

"The drug Verelan is used to treat irregular heart rhythms and belongs to a class of drugs known as antidysrhythmics, calcium channel blockers, and non-dihydropyridine calcium channel blockers."

Answered by AI

Can I take verapamil at night?

"You should take verapamil at around the same time(s) every day. Some verapamil products should be taken in the morning, and others should be taken at bedtime."

Answered by AI

Clinical Trials for Verelan Pm

Image of Miles Square Health Center Chicago in Chicago, United States.

Food is Medicine for High Blood Pressure and Obesity

Any Age
All Sexes
Chicago, IL

The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?

Phase 2
Waitlist Available

Miles Square Health Center Chicago (+3 Sites)

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL

This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.

Waitlist Available
Has No Placebo

U Health (+1 Sites)

Ziad Zoghby, M.D., M.B.A.

Biobeat Technologies Ltd.

Have you considered Verelan Pm clinical trials?

We made a collection of clinical trials featuring Verelan Pm, we think they might fit your search criteria.
Go to Trials
Image of Tampa General Hospital in Tampa, United States.

Fasting for Myocardial Infarction

18+
All Sexes
Tampa, FL

The goal of this clinical trial is to find out whether fasting is necessary before urgent inpatient cardiac catheterizations. For patients presenting with urgent heart-related pain or even mild heart attacks, researchers want to know whether eating and drinking before their procedure improves comfort without raising the risk of complications. The study will answer: * Does eating and drinking before the procedure improve patient comfort? * Does it increase the risk of adverse events like vomiting, aspiration (food or liquid entering the lungs), breathing problems, or death, etc? Participants will be randomly assigned to either: * A standard fasting group (no food for 6 hours, no clear liquids for 2 hours), or * A no-fasting group (able to eat and drink as usual). Patients will complete brief surveys before the procedure to assess comfort and satisfaction. Researchers will also review medical records weekly and 30 days later to monitor for safety outcomes.

Recruiting
Has No Placebo

Tampa General Hospital

Samip Vasaiwala, MD

Have you considered Verelan Pm clinical trials?

We made a collection of clinical trials featuring Verelan Pm, we think they might fit your search criteria.
Go to Trials
Image of University of Alberta in Edmonton, Canada.

Egg White Powder for High Blood Sugar and High Blood Pressure

18 - 70
All Sexes
Edmonton, Canada

Bioactive peptides derived from food proteins show potential for improving human health. One of such promising peptides is namely IRW made from egg white hydrolysate and composed of three peptides. This is a feasibility study to assess the acute effect of IRW in egg white hydrolysate for the management of high sugar and blood pressure. Participants at high risk of type 2 diabetes (T2D) or having T2D will undergo 4 consecutive treatments of 1 day each (randomly), during which they will consume a standardized breakfast with a smoothie containing different protein powders. Each treatment will be separated by a minimum of 1-week. Participants in the healthy control group will undergo 1 treatment only (one day).

Phase 1
Recruiting

University of Alberta

Jianping Wu, PhD

Image of Northern Arizona University in Flagstaff, United States.

CardioCare Quest for High Blood Pressure

18+
All Sexes
Flagstaff, AZ

This project aims to address healthcare disparities among Navaho people diagnosed with hypertension or prehypertension through three main objectives. Firstly, it identifies and shares insights on healthcare access disparities affecting Navaho individuals experiencing nonadherence to hypertension treatment. Secondly, the proposal develops a telehealth solution based on factors identified as knowledge gaps caused by healthcare access disparities in hypertension management; we will use the factors to design a series of engaging minigames that can be incorporated into the larger CardioCare Quest. These minigames will be co-designed with end users and clinicians. Finally, the proposal conducts comprehensive qualitative and quantitative assessments of user experiences, perceptions, and challenges with CardioCare Quest.

Recruiting
Has No Placebo

Northern Arizona University (+1 Sites)

Tochukwu Ikwunne, PhD

Have you considered Verelan Pm clinical trials?

We made a collection of clinical trials featuring Verelan Pm, we think they might fit your search criteria.
Go to Trials